We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AON:NYSEAon plc Analysis

Data as of 2026-03-10 - not real-time

$332.84

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: The 20‑day SMA sits below both the 50‑day and 200‑day SMAs, reinforcing a bearish price trend, while the RSI hovers around the neutral 50 mark and the MACD histogram remains positive, suggesting limited upside momentum. Volatility is elevated, exceeding 30% over the past month, but the stock’s beta is modest, indicating limited systematic risk.
Fundamental backdrop: Aon delivers robust profitability with high operating margins and an exceptional ROE, and its dividend payout ratio is comfortably low, supporting dividend sustainability. The DCF‑derived fair value is markedly below the current market price, flagging a potential overvaluation, yet analysts maintain a consensus “buy” with a target price above today’s level. Recent strategic moves—including the consolidation of Mumbai offices and the appointment of a new CEO for Risk Capital—signal continued focus on operational efficiency and growth in high‑margin segments. Together, these factors suggest that while short‑term price pressure may persist, the company’s strong cash generation and strategic positioning underpin a favorable longer‑term outlook.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish SMA alignment and decreasing volume
  • Elevated short‑term volatility
  • Positive MACD histogram offering limited upside

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong operating margins and high ROE
  • Strategic leadership changes in Risk Capital
  • Analyst consensus and target price above current level

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustainable dividend with low payout ratio
  • Diversified global footprint reducing geographic concentration
  • Continued cash flow generation supporting growth initiatives

Key Metrics & Analysis

Financial Health

Revenue Growth3.70%
Profit Margin21.51%
P/E Ratio19.5
ROE46.94%
ROA5.89%
Debt/Equity168.32
P/B Ratio7.6
Op. Cash Flow$3.5B
Free Cash Flow$3.1B
Industry P/E17.4

Technical Analysis

TrendBearish
RSI49.6
Support$304.59
Resistance$344.65
MA 20$326.40
MA 50$338.19
MA 200$351.68
MACDBullish
VolumeDecreasing
Fear & Greed Index75.89

Valuation

Fair Value$168.46
Target Price$397.42
Upside/Downside19.40%
GradeOvervalued
TypeGrowth
Dividend Yield0.87%

Risk Assessment

Beta0.32
Volatility38.12%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.